4
Changes in Ownership
Lexaria Bioscience Corp. Filed Acc 0001855763-22-000002
Options or other derivatives
- Director acquired 3,400 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| McKechnie William Edward Director | 2022-03-08 | Grant or award · Stock Options | +3,400 | 11,800 | D | ||
Loading xslF345X03/primary_doc.xml…